ARK Genomic Revolution ETF
ARKG
106 hedge funds and large institutions have $173M invested in ARK Genomic Revolution ETF in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 18 closing their positions.
160% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 15
89% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 18
22% more capital invested
Capital invested by funds: $142M → $173M (+$31.1M)
14% more funds holding
Funds holding: 93 → 106 (+13)
4.8% more ownership
Funds ownership: 28.71% → 33.51% (+4.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$11.5M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10M |
| 3 |
CPA
Capital Planning Advisors
Roseville,
California
|
+$4.82M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.62M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UAM
UAS Asset Management
New York
|
-$2.35M |
| 2 |
PCM
Penserra Capital Management
Orinda,
California
|
-$1.49M |
| 3 |
CAN
Claraphi Advisory Network
Aliso Viejo,
United States
|
-$1.37M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$746K |
| 5 |
HT
HAP Trading
New York
|
-$682K |
ARKG Hedge Fund Activity: Q1 2020 in Review
106 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2020, worth a combined $173M — up 22% from $142M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ARKG positions and 18 closed out — a net gain of 16 holders — while 39 added to existing stakes and 15 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $11.5M. The largest seller was UAS Asset Management, exiting entirely with an estimated $2.35M sold.
- 106 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2020, up from 93 in Q4 2019.
- Funds reported $173M of ARK Genomic Revolution ETF stock for Q1 2020, up 22% quarter-over-quarter.
- 34 funds opened new ARK Genomic Revolution ETF positions in Q1 2020 and 18 closed out, a net change of +16 holders.
- The largest ARK Genomic Revolution ETF buyer in Q1 2020 was Morgan Stanley, an estimated $11.5M added.
- The largest ARK Genomic Revolution ETF seller in Q1 2020 was UAS Asset Management, an estimated $2.35M sold.
Based on aggregated 13F filings for Q1 2020.